NU

Nassim Usman

President & CEO, Member Board of Directors at Totus Medicines

South San Francisco, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Start-up Ventures
Board of Directors
Cancer Research
Clinical Trials
Executive Leadership
Management
Business Strategy
Business Development
Audit Committee
Strategic Thinking
Life Sciences
Pharmaceutical Industry
Technology Transfer
Biotechnology
Corporate Development
Venture Capital
Start-ups
Drug Discovery
Entrepreneurship
Biopharmaceuticals

Education

Lists including Nassim

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Principia Biopharma

Series A

Total Funding: $78M

Catalyst Biosciences

Post Ipo Equity

Total Funding: $88M

Work Experience

TM
Totus Medicines

2023

  • President & Chief Executive Officer

    2023

Morgenthaler Ventures

2005

  • Entrepreneur in Residence & Venture Partner

    2005

Gyre Therapeutics

2023 - 2024

  • Member Board of Directors

    2023 - 2024

CB
Catalyst Biosciences

2006 - 2023

  • President & CEO, Member Board of Directors

    2006 - 2023

MB
Mosaic Biosciences

2011 - 2020

  • Member Board Of Directors

    2011 - 2020

PB
Principia Biopharma

2011 - 2018

  • Member Board Of Directors

    2011 - 2018

Sirna Therapeutics

2003 - 2005

  • COO & CSO

    2003 - 2005

Atugen AG

1999 - 2003

  • Member Of The Supervisory Board

    1999 - 2003

Ribozyme Pharmaceuticals

1992 - 2003

  • VP R&D & CSO

    1992 - 2003

MI
Massachusetts Institute of Technology (MIT)

1987 - 1992

  • Postdoctoral Fellow, Staff Scientist

    1987 - 1992